Global Influenza Rapid Diagnostic Tests Market Competitions From Opponents Research 2022- Thermo Fisher Scientific, Hologic, Quidel Corporation

Global Influenza Rapid Diagnostic Tests Market Competitions From Opponents Research 2022- Thermo Fisher Scientific, Hologic, Quidel Corporation

Influenza Rapid Diagnostic Test Market Study: Influenza A+B Tests to Account for Largest Market Share. Influenza Rapid Diagnostic Test Market Segmented By Immunochromatographic Assays, Immunofluorescence Assays, Influenza A Assay Nucleic Acid Amplification Test Principle, Influenza B Assay, Influenza A+B Test Type By Throat Swab, Wash nasal, nasopharyngeal aspirate sample type. The influenza diagnostic market is quite competitive. Furthermore, technological improvements and innovations to provide fast, accurate and low-cost disease diagnostics are a crucial factor creating an opportunity for market competitors.

global Influenza Rapid Diagnostic Test Market It is classified into different types of products that are intended to perform different applications in various industries. Some of the common sectors that are implementing these products in their business processes include automotive, healthcare, construction, electrical, and other select sectors. These companies have understood the efficacy of the products listed in the global Influenza Rapid Diagnostic Tests Market. Therefore, the demand rates have increased to staggering levels. Along with the demands, the supply chain has also evolved. The key players are making a collective effort to make sure the manufacturing infrastructure thrives. With higher production, demand requests can also be fulfilled on a priority basis without running out of stock.

Influenza rapid diagnostic tools are expected to exceed US$2 billion by 2031, while expanding at a CAGR of 8.7%. Increased adoption of rapid influenza test kits, increased awareness for early detection using specific diagnostic tests, development of CLIA-exempt POC molecular influenza tests, and shifting focus from centralized laboratories to point-of-care testing. decentralized care are some of the key trends seen in this market.

Get a free sample copy of this [email protected] https://www.persistencemarketresearch.com/samples/31040

Influenza is recognized as a major source of human illness and mortality, prompting the development and implementation of diagnostics aimed at lessening health and economic consequences. Influenza causes severe illness or death, primarily in high-risk people.

With the start of flu season comes an increase in the use of antibiotics, raising the danger of antibiotic resistance in the body. The fast response times of the devices used at the point of care help in the preparation of a specific and successful treatment plan based on the test results. Rapid influenza diagnostic tests have a short turnaround time, with some providing results in less than 15 minutes. As a result, the adoption of rapid influenza diagnostic tests helps prevent overprescription of antibiotics, as well as avoid the root cause of bacterial resistance and its negative consequences.

The current COVID-19 pandemic has also fueled the demand for rapid influenza diagnostic tests. Compared to influenza, COVID-19 has a similar disease presentation: both viruses cause respiratory problems. Also, both are spread through touch, droplets, and fomites. COVID-19 patients have been misdiagnosed with influenza in the past, which has increased the demand for rapid virus detection kits.

The emergence of smartphone-based disease detection has increased the revenue of the market. The Human Genome Project and advances in molecular and biomedical technology have led to the creation of a plethora of useful assays and technologies for diagnosing and monitoring influenza infections. These new technologies, which are based on genomic (PCR-based) and proteomic (microarray-based detection) techniques, help in the discovery of new influenza viruses. They also enable better surveillance and rapid detection of infectious diseases, presenting a good business opportunity for market players.

Company profiles:

Thermo Fisher Scientific, Hologic, Quidel Corporation, F. Hoffmann-La Roche AG, Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, Meridian Bioscience, bioMérieux SA, Luminex Corporation, Siemens Healthineers AG, GenMark Diagnostics, Sekisui Diagnostics, LLC altona Diagnostics GmbH, SA Scientific, ELITech Group and more

Application [email protected] https://www.persistencemarketresearch.com/methodology/31040

market-for-flu-rapid-diagnostic-tests

Key takeaways from the market study

  • Leading, immunochromatographic assays have a high share of 66.8% in 2021, with a CAGR of 6.1% during the forecast period.
  • By test type, the Influenza A+B test is expected to have a 79% market share and is expected to continue to grow at a similar trend due to its benefits such as ease of use and rapid diagnosis.
  • By sample, the nasopharyngeal swab segment is expected to have a 31% market share, with nasopharyngeal aspirate being the second leading segment, accounting for 27.5%.
  • Per end user, the office-based setup accounts for almost 22.5% of the market share.
  • By region, North America had 36.6% of the global market share in 2021.

“Increasing demand for rapid disease diagnosis, rising prevalence of influenza, and increased research into diagnostic technologies are expected to provide growth opportunities for market players.” says an analyst at Persistence Market Research.

full access [email protected] https://www.persistencemarketresearch.com/checkout/31040

Influenza Rapid Diagnostic Test Market: Report Highlights

  • A detailed overview of the main market of the Influenza Rapid Diagnostic Tests market
  • Changing market dynamics Influenza Rapid Diagnostic Tests in industry
  • Detailed Segmentation of the Rapid Influenza Diagnostic Tests Market
  • Historical, Current, and Projected Rapid Influenza Diagnostic Tests Market Size with Respect to Volume and Value
  • Recent industry trends and developments in the Influenza Rapid Diagnostic Tests Market
  • Competitive Landscape of the Rapid Influenza Diagnostic Tests Market
  • Strategies for key players and products offered
  • Potential and niche segments, geographic regions showing promising growth
  • A neutral perspective on the performance of the Influenza Rapid Diagnostic Tests market

Must-know information for Influenza Rapid Diagnostic Tests Market players maintain and improve their footprint in the market

Major Market Research Reports:

High content projection

animal drug compound

Chromatographic Separation Resins

overweight treatment

On Persistence Market Research:

PersistenceMarketResearch is an esteemed company with a reputation for serving clients in the Information Technology (IT), Healthcare, and Chemicals domains. Our analysts conduct extensive primary and secondary research to provide a seamless report with a 360-degree perspective. The data is compared with reputable organizations, trusted databases and international surveys to produce impeccable reports backed up with graphical and statistical information.

Media Contact:

Persistence Market Research

305 Broadway, 7th Floor New York, NY 10007 United States

Call +1-646-568-7751

Call +1 800-961-0353

[email protected]

This press release has been written with the intention of providing accurate market information that will enable our readers to make informed strategic investment decisions. If you notice any issues with this content, please feel free to contact us at [email protected]

Leave a Comment